Atezolizumab (anti-PD-L1)

Atezolizumab (anti-PD-L1) is a fully humanized, IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1, but not the interaction of PD-L2 with PD-1. MW : 145 KD.
Supplier Selleck Chemicals
Product # A2004
Sku # A2004-1mg*5
Pricing 1mg*5, $707.00
Feedback